Evidence map›Paper›PMID 23545711›Full record

ArticleThe American journal of gastroenterology2013

Biliary self-expandable metal stents do not adversely affect pancreaticoduodenectomy.

Lianne K Cavell, Peter J Allen, Cjloe Vinoya, Anne A Eaton, Mithat Gonen, Hans Gerdes, Robin B Mendelsohn, Michael I D'Angelica, T Peter Kingham, Yuman Fong and 4 more

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in The American journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06453590 (Palliative Treatment of Distal Malignant Biliary Obstruction by Endoscopic Stents), which is not on this map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06453590 naactive not recruitingnot on this mapstarted 2020, after this paper: background citation

Palliative Treatment of Distal Malignant Biliary Obstruction by Endoscopic Stents: Uncovered, Partially Covered, or Fully Covered Metal Stents: A Prospective Randomized Multicenter Study

TypeinterventionalSponsorRegion StockholmRan2020 to 2027Enrolled450ConditionsPancreatic Cancer Non-resectable, Bile Duct Cancer, Papillary Carcinoma, Duodenal CancerArmsRandomization to uncovered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to partially covered SEMS treating jaundice due to distal malignant biliary obstruction., Randomization to fully covered SEMS treating jaundice due to distal malignant biliary obstruction.
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Surgical management of biliary malignancy.Current problems in surgery · 2021
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Lianne K CavellDepartment of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Peter J Allen
Cjloe Vinoya
Anne A Eaton
Mithat Gonen
Hans Gerdes
Robin B Mendelsohn
Michael I D'Angelica
T Peter Kingham
Yuman Fong
Ronald Dematteo
William R Jarnagin
Robert C Kurtz
Mark A Schattner
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesControversy exists regarding whether to place a plastic or a metal endobiliary stent in patients with resectable pancreatic cancer who require biliary drainage. Although self-expandable metal stents (SEMS) provide better drainage compared with plastic stents, concerns remain that SEMS may compromise resection and increase postoperative complications. Our objective was to compare surgical outcomes of patients undergoing pancreaticoduodenectomy (PD) with SEMS in place vs. plastic endoscopic stents (PES) and no stents (NS).

methodsWe performed a retrospective analysis from a prospective database of all patients undergoing either attempted or successful PD with SEMS, PES, or NS in place at the time of operation. Patients were compared with regard to perioperative complications, margin status, and the rate of intraoperative determination of unresectability.

resultsA total of 593 patients underwent attempted PD. Of these, 84 patients were locally unresectable intraoperatively and 509 underwent successful PD, of which 71 had SEMS, 149 had PES, and 289 had NS. Among patients who had a preoperative stent, SEMS did not increase overall or serious postoperative complications, 30-day mortality, length of stay, biliary anastomotic leak, or positive margin, but was associated with more wound infections and longer operative times. In those with adenocarcinoma, intraoperative determination of local unresectability was similar in the SEMS group compared with other groups, with 16 (19.3%) in SEMS compared with 29 (17.7%) in PES (P=0.862), and 31 (17.5%) in NS (P=0.732).

conclusionsPlacement of SEMS is not contraindicated in patients with resectable pancreatic cancer who require preoperative biliary drainage.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAnastomotic LeakCholestasisDrainageFemaleHumansLength of StayMaleMetalsMiddle AgedNeoplasm, ResidualPancreatic NeoplasmsPancreaticoduodenectomyMetalsPlastics

Identifiers

PMID23545711
PMCPMC4159071
OpenAlexW2012947493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.